Dr. Kapila Ratnam joined NewSpring in 2007 and is a General Partner of NewSpring and the Firm’s dedicated healthcare funds. Prior to joining NewSpring, she worked in the health sciences division at PSI International, a firm that provides outsourced services to the pharmaceutical industry and government health service agencies. Before PSI, she served as a strategy consultant to early stage pharmaceutical services and biotech companies; and worked in R&D at GlaxoSmithKline Pharmaceuticals, that researches, develops and manufactures innovative pharmaceutical medicines, vaccines and consumer healthcare products. Kapila received an MBA from Columbia University and a Ph.D. from The Ohio State University.